PhaseBio Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.00
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.35
|
0.00
|
0.35
|
100.00%
|
|
2022-06-30
|
-0.31
|
-0.34
|
-0.03
|
-9.68%
|
|
2022-03-31
|
-0.66
|
-0.23
|
0.43
|
65.15%
|
|
2021-12-31
|
-0.59
|
-0.90
|
-0.31
|
-52.54%
|
|
2021-09-30
|
-0.61
|
-0.66
|
-0.05
|
-8.20%
|
|
2021-06-30
|
-0.46
|
-0.60
|
-0.14
|
-30.43%
|
|
2021-03-31
|
-0.73
|
-0.87
|
-0.14
|
-19.18%
|
|
2020-12-31
|
-0.70
|
-1.03
|
-0.33
|
-47.14%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.57
|
|
2021-12-31
|
-3.03
|
|
2020-12-31
|
-3.39
|
|
2019-12-31
|
-1.42
|
|
2018-12-31
|
-12.05
|